Table 3.

Adverse Events Recorded in Real-World Studies

Adverse Event	% Occurrence
Infusion-related reaction	1.8–3.2
Dyspnea	0.9–20
Fatigue	0.3–9
Thyroiditis	0.6–3
Abdominal Pain	0.3–18
Hepatitis	0.3–5